Lataa...
Elucidating Differences in the Hepatotoxic Potential of Tolcapone and Entacapone With DILIsym(®), a Mechanistic Model of Drug‐Induced Liver Injury
Tolcapone and entacapone are catechol‐O‐methyltransferase (COMT) inhibitors developed as adjunct therapies for treating Parkinson's disease. While both drugs have been shown to cause mitochondrial dysfunction and inhibition of the bile salt export protein (BSEP), liver injury has only been asso...
Tallennettuna:
| Julkaisussa: | CPT Pharmacometrics Syst Pharmacol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4728295/ https://ncbi.nlm.nih.gov/pubmed/26844013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12053 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|